Jubilant Pharmova Limited (JUBLPHARMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Jubilant Pharmova Limited (JUBLPHARMA) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.69 Billion ≈ $39.91 Million USD) by net assets (Rs65.72 Billion ≈ $710.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jubilant Pharmova Limited market cap and net worth for the company's overall valuation and market capitalisation.

Jubilant Pharmova Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Jubilant Pharmova Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jubilant Pharmova Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jubilant Pharmova Limited ranked by their cash flow conversion efficiency. Explore Jubilant Pharmova Limited (JUBLPHARMA) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Bikaji Foods International Limited NSE:BIKAJI	0.061x
Shanghai Highly Group Co Ltd A SHG:600619	0.019x
V-Guard Industries Limited NSE:VGUARD	0.082x
Zhejiang Expressway Co. Ltd F:ZHJ	0.012x
Dongguan Eontec Co Ltd SHE:300328	-0.047x
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A SHG:600648	0.009x
Shinkong Insurance Co Ltd TW:2850	0.144x
Holmen AB (publ) ST:HOLM-A	0.019x

Annual Cash Flow Conversion Efficiency for Jubilant Pharmova Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Jubilant Pharmova Limited from 2004 to 2025. View Jubilant Pharmova Limited (JUBLPHARMA) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs62.39 Billion ≈ $674.68 Million	Rs10.72 Billion ≈ $115.94 Million	0.172x	-4.09%
2024-03-31	Rs54.21 Billion ≈ $586.27 Million	Rs9.71 Billion ≈ $105.04 Million	0.179x	+46.22%
2023-03-31	Rs53.92 Billion ≈ $583.10 Million	Rs6.61 Billion ≈ $71.45 Million	0.123x	-22.22%
2022-03-31	Rs53.16 Billion ≈ $574.95 Million	Rs8.38 Billion ≈ $90.58 Million	0.158x	-58.14%
2021-03-31	Rs47.42 Billion ≈ $512.78 Million	Rs17.84 Billion ≈ $192.96 Million	0.376x	+36.67%
2020-03-31	Rs56.04 Billion ≈ $606.04 Million	Rs15.43 Billion ≈ $166.86 Million	0.275x	+18.06%
2019-03-31	Rs48.09 Billion ≈ $520.08 Million	Rs11.22 Billion ≈ $121.29 Million	0.233x	-27.79%
2018-03-31	Rs40.35 Billion ≈ $436.37 Million	Rs13.03 Billion ≈ $140.94 Million	0.323x	-13.51%
2017-03-31	Rs33.97 Billion ≈ $367.35 Million	Rs12.68 Billion ≈ $137.18 Million	0.373x	-0.53%
2016-03-31	Rs29.10 Billion ≈ $314.66 Million	Rs10.92 Billion ≈ $118.13 Million	0.375x	+17.60%
2015-03-31	Rs24.54 Billion ≈ $265.34 Million	Rs7.83 Billion ≈ $84.71 Million	0.319x	+10.75%
2014-03-31	Rs27.84 Billion ≈ $301.13 Million	Rs8.03 Billion ≈ $86.80 Million	0.288x	-22.56%
2013-03-31	Rs26.06 Billion ≈ $281.82 Million	Rs9.70 Billion ≈ $104.90 Million	0.372x	+26.19%
2012-03-31	Rs23.99 Billion ≈ $259.41 Million	Rs7.08 Billion ≈ $76.52 Million	0.295x	+68.29%
2011-03-31	Rs22.14 Billion ≈ $239.44 Million	Rs3.88 Billion ≈ $41.97 Million	0.175x	-44.69%
2010-03-31	Rs22.39 Billion ≈ $242.17 Million	Rs7.10 Billion ≈ $76.74 Million	0.317x	-28.02%
2009-03-31	Rs12.68 Billion ≈ $137.08 Million	Rs5.58 Billion ≈ $60.35 Million	0.440x	+21.03%
2008-03-31	Rs12.56 Billion ≈ $135.85 Million	Rs4.57 Billion ≈ $49.42 Million	0.364x	+72.91%
2007-03-31	Rs9.06 Billion ≈ $98.00 Million	Rs1.91 Billion ≈ $20.62 Million	0.210x	+1147.30%
2006-03-31	Rs8.41 Billion ≈ $90.93 Million	Rs141.82 Million ≈ $1.53 Million	0.017x	-92.38%
2005-03-31	Rs5.04 Billion ≈ $54.56 Million	Rs1.12 Billion ≈ $12.08 Million	0.221x	-44.92%
2004-03-31	Rs2.10 Billion ≈ $22.69 Million	Rs843.14 Million ≈ $9.12 Million	0.402x	--

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

Rs146.43 Billion INR

Market Cap Rank

#7061 Global

#347 in India

Share Price

Rs924.50

Change (1 day)

+1.83%

52-Week Range

Rs807.65 - Rs1181.20

All Time High

Rs1269.00